Seeing Is Believing
BOLD is currently covered by 3 analysts with an average price target of $42.85. This is a potential upside of $41.75 (3795.45%) from yesterday's end of day stock price of $1.1.
Audentes Therapeutics's activity chart (see below) currently has 62 price targets and 19 ratings on display. The stock rating distribution of BOLD is 16.67% HOLD and 83.33% BUY.
Analysts average stock forecasts to be materialized ratio is 7.69% with an average time for these price targets to be met of 12.46 days.
Highest price target for BOLD is $4, Lowest price target is $3, average price target is $3.5.
Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 11-Aug-2025.
Currently out of the existing stock ratings of BOLD, 1 are a HOLD (16.67%), 5 are a BUY (83.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Jun-2025
$4
$2.89 (260.36%)
$5
7 months 21 days ago
(11-Aug-2025)
0/2 (0%)
$2.89 (260.36%)
Hold Since 28-May-2025
$3
$1.89 (170.27%)
$25
10 months 4 days ago
(28-May-2025)
0/2 (0%)
$1.8 (150.00%)
Hold Since 04-Dec-2019
$60
$58.89 (5305.41%)
$48
6 years 3 months 28 days ago
(04-Dec-2019)
0/4 (0%)
$60 (0.00%)
Hold Since 03-Dec-2019
$60
$58.89 (5305.41%)
$55
6 years 3 months 29 days ago
(03-Dec-2019)
0/10 (0%)
$60 (0.00%)
Hold Since 03-Dec-2019
$60
$58.89 (5305.41%)
$21
6 years 3 months 29 days ago
(03-Dec-2019)
0/3 (0%)
$60 (0.00%)
What is BOLD (Audentes Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on BOLD (Audentes Therapeutics) with a proven track record?
Which analyst has the most public recommendations on BOLD (Audentes Therapeutics)?
Which analyst is the currently most bullish on BOLD (Audentes Therapeutics)?
Which analyst is the currently most reserved on BOLD (Audentes Therapeutics)?